Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting-Reference-Cited by-同舟云学术

Compliance, Behavior Change, and Weight Loss With Orlistat in an Over-the-Counter Setting

Published:2008-03 Issue:3 Volume:16 Page:623-629
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:

Author:

Schwartz Susan M.,Bansal Vidhu P.,Hale Cecilia,Rossi Maureen,Engle Janet P.

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/oby.2007.96/fullpdf

Reference17 articles.

1. National Center for Health Statistics (CDC) Prevalence of Overweight and Obesity Among Adults: United States, 2003-2004 http:www.cdc.govnchsproductspubspubdhestatsoverweightoverwght_adult_03.htm 2007

2. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers;Zhi;Clin Pharmacol Ther,1994

3. Jacob S. Togerson J. Orlistat Treatment Beneficial in Both Primary Care and Tertiary Settings Presented at European Congress of Obesity 1 4 2005

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of drugs for obesity;BMJ;2024-03-25

2. Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM;Clinical Therapeutics;2024-03

3. Regulatory, safety and economic considerations of over-the-counter medicines in the Indian population;Discover Health Systems;2023-05-22

4. How can real‐world evidence aid decision making during the life cycle of nonprescription medicines?;Clinical and Translational Science;2021-11-15

5. Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review;Obesity Reviews;2021-08-22